Sean Li, MD
Anesthesiology
Interventional Pain Management
National Spine & Pain Centers
Shrewsbury, NJ
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Sean Li, MD, has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Avanos, Biotronik, Boston Scientific, Nalu, Nevro Corp., PainTEQ, Saluda Medical, SI-BONE, SPR Therapeutics, Vertos Medical; Grant/Research Support: Avanos, Biotronik, Boston Scientific, Nevro Corp., Saluda Medical, SGX Medical, SPR Therapeutics; Speaker's Bureau: Gruenthal Pharmaceuticals; Shareholder: Nalu, National Spine and Pain Centers.
Douglas P. Badertscher has no financial relationships to disclose.
Marshall Bedder, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speaker's Bureau: Boston Scientific.
Kenneth B. Chapman, MD, has no financial relationships to disclose.
Corey A. Cines, CPA, has no financial relationships to disclose.
Mark H. Coleman, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Vertos Medical, Abbott, Aurora Spine.
Shravani Durbhakula, MD, has no financial relationships to disclose.
Brian Durkin, DO, D.ABA, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Vertos Medical, Nevro Corp., Relievant, Avanos.
Ali El-Mohandes, MD, has no financial relationships to disclose.
Michael A. Fishman, MD, MBA, , and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Aurora Pain Care, Biotronik, Camber Spine, Medtronic, and Thermaquil; Grant/Research Support: Abbott, Biotronik, InterAxon, Lumbrera, Medtronic, Nalu Medical, Saluda Medical, Stimgenics, Thermaquil, Vertiflex; Speaker's Bureau: Abbott, Aurora Spine, IMSE, Medtronic; Shareholder: Celeri Health, Thermaquil.
Mayo Friedlis, MD, has no financial relationships to disclose.
Christopher Gilligan, MD, MBA, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic, Abbott, Saluda Medical, Persica, Iliad Lifesciences; Grant/Research Support: Mainstay Medical, Sollis Therapeutics; Other Financial/Material Support: Expert Witness.
Sassan Hassassian, MD, has no financial relationships to disclose.
Michael Hoffmann, MD, PhD, has no financial relationships to disclose.
Corey W. Hunter, MD, FIPP, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Saluda Medical; Grant/Research Support: Abbott, Saluda Medical, Biotronik, Mesoblast, Discgenics, VIVEX Biologics; Shareholder: Nalu, Mainstay, Spine Biopharma, PainTEQ, VIVEX Biologics.
Philip Keck, PhD, has no financial relationships to disclose.
William L. Koleszar, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Employee: National Spine & Pain Centers.
Neil Kunkel, Esq., has no financial relationships to disclose.
Paul J. Kuzma, MD, MPH, has no financial relationships to disclose.
Robert M. Levy, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Shareholder: Stock options from Nalu and Saluda Medical obtained prior to 2019, and not exercisable through the duration as my term as INS President, and Editor-in-Chief of the journal, Neuromodulation Technology at the Neural Interface.
Sean Li, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Avanos, Biotronik, Boston Scientific, Nalu, Nevro Corp., PainTEQ, Saluda Medical, SI-BONE, SPR Therapeutics, Vertos Medical; Grant/Research Support: Avanos, Biotronik, Boston Scientific, Nevro Corp., Saluda Medical, SGX Medical, SPR Therapeutics; Speaker's Bureau: Gruenthal Pharmaceuticals; Shareholder: Nalu, National Spine and Pain Centers.
Vipul Mangal, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic, Aurora Spine; Grant/Research Support: Medtronic, Abbott, Boston Scientific, Nevro, Aurora Spine; Shareholder: Aurora Spine.
Neel Mehta, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Nevro Corp., Salix; Grant/Research Support: Nevro Corp.
Dontese J. Nicholson, MD, has no financial relationships to disclose.
Anish S. Patel, MD, MBA, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Nevro Corp., Medtronic, Abbott, Flowonix, Camber Spine; Shareholder: Aurora Spine, AIS Healthcare.
Ketan Patel, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic, Abbott, BioDelivery Sciences International.
Marina G. Protopapas, DO, has no financial relationships to disclose.
Gabor B. Racz, MD, FIPP, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Epimed; Speaker's Bureau: Epimed, Stimwave; Shareholder: Stimwave.
David E. Reece, DO, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speaker’s Bureau: Medtronic, Nevro, Abbott.
Adam Sackstein, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Versea.
Cherian K. Sajan, MD, has no financial relationships to disclose.
David Spinner, DO, has no financial relationships to disclose.
Peter S. Staats, MD, MBA, FIPP, ABIPP, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: National Spine & Pain Centers; Shareholder: electroCore, National Spine & Pain Centers, Saluda Medical, SPR Therapeutics; Other Financial/Material Support: electroCore, SPR Therapeutics (Chief Medical Officer).
Gregg M. Taboh has no financial relationships to disclose.
Ricardo Vallejo, MD, PhD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic; Speaker’s Bureau: Medtronic; Shareholder: SGX-Medical (No Commercial Product).
Douglas W. Wisor, MD, has no financial relationships to disclose.
Jonathan (JT) Wu has no financial relationships to disclose.
The Evolve staff/planners and Mantra Meetings staff/planners have no financial relationships with commercial interests.
Phillip Keck, PhD, LCP, peer reviewer, has no relevant financial relationships with commercial interests.
